Adagio Medical Holdings (ADGM) Liabilities and Shareholders Equity (2023 - 2026)

Adagio Medical Holdings (ADGM) has 4 years of Liabilities and Shareholders Equity data on file, last reported at $39.3 million in Q1 2026.

• Liabilities and Shareholders Equity for Q1 2026 came in at $39.3 million, down 4.91% year-over-year; the trailing twelve-month figure through Mar 2026 was $150.0 million (down 23.86% YoY), and the FY2025 annual result was $43.3 million, down 10.72% from the prior year.
• Liabilities and Shareholders Equity fell to $39.3 million in Q1 2026 per ADGM's latest filing, from $43.3 million in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $107.2 million in Q3 2024 and troughed at $6.8 million in Q4 2023.
• A 4-year average of $44.2 million and a median of $40.3 million in 2025 frame the typical range for Liabilities and Shareholders Equity.
• The sharpest annual moves came in 2024 and 2025: Liabilities and Shareholders Equity surged 609.86% in 2024, then sank 70.57% in 2025.
• A 4-year view of Liabilities and Shareholders Equity shows it stood at $6.8 million in 2023, then surged by 609.86% to $48.4 million in 2024, then fell by 10.72% to $43.3 million in 2025, then dropped by 9.12% to $39.3 million in 2026.
• Business Quant data shows ADGM's Liabilities and Shareholders Equity at $39.3 million in Q1 2026, $43.3 million in Q4 2025, and $31.5 million in Q3 2025.